Theresa Tam | Chief Public Health Officer Of Canada
Public Health Agency of Canada

Theresa Tam, Chief Public Health Officer Of Canada, Public Health Agency of Canada

Dr Theresa Tam was named Canada’s Chief Public Health Officer on June 26, 2017. She is a physician with expertise in immunization, infectious disease, emergency preparedness and global health security.

Dr Tam obtained her medical degree from the University of Nottingham in the U.K. She completed her paediatric residency at the University of Alberta and her fellowship in paediatric infectious diseases at the University of British Columbia. She is a Fellow of the Royal College of Physicians and Surgeons of Canada and has over 55 peer-reviewed journal publications in public health. She is also a graduate of the Canadian Field Epidemiology Program.
Dr Tam has held several senior leadership positions at the Public Health Agency of Canada, including as the Deputy Chief Public Health Officer and the Assistant Deputy Minister for Infectious Disease Prevention and Control. During her 20 years in public health, she provided technical expertise and leadership on new initiatives to improve communicable disease surveillance, enhance immunization programs, strengthen health emergency management and laboratory biosafety and biosecurity. She has played a leadership role in Canada's response to public health emergencies including severe acute respiratory syndrome (SARS), pandemic influenza H1N1 and Ebola.

Dr Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.

Appearances:



April 14 Pre-congress Workshop Day @ 10:00

WORKSHOP D: BIODEFENCE

The role of vaccines in preventing outbreaks, through natural causes or biothreats It only takes natural outbreaks and bioterrorism attacks like the Ebola and anthrax to highlight the danger and fragile balance we live in. To ensure global and international security, important decisions need to be made in stockpiling and prioritizing research efforts, however there is a lack of vaccine manufacturers producing these countermeasure treatments. Participate in this workshop to understand the rationale for developers to produce these lower commercial interest vaccines, and the challenges/opportunities associated in working with the government. Workshop leader: Col Matthew Hepburn, Program Manager, DARPA
  • Government strategy in pre-preparedness
  • Strategy for civilian population response, post outbreak
  • Challenges and outlook of vaccine development during unknown outbreaks
  • Platforms suitable for rapid response and emergency outbreaks
  • The importance of a One Health approach to biodefense and biosecurity
  • Regulatory consideration for the development and licensure of vaccines to prevent emerging infectious disease outbreaks and biothreats

April 15 Plenary Congress Day 1 @ 09:45

How can we be better prepared for disease X?

  • What kind of regulatory and political support can we expect?
  • Prevention and pre-prepared efforts to ensure our current and future safety
  • Vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development
last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071